Catalyst Pharmaceuticals, Inc. (CPRX)

NASDAQ: CPRX · Real-Time Price · USD

23.84

-0.46 (-1.89%)

Feb 23, 2026, 12:39 PM EST - Market open

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Development and Commercialization of Drug Products	491.73M	398.20M	214.20M	140.83M	119.07M
Development and Commercialization of Drug Products Growth	23.49%	85.90%	52.10%	18.27%	16.39%
Total	491.73M	398.20M	214.20M	140.83M	119.07M
Total Growth	23.49%	85.90%	52.10%	18.27%	16.39%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
United States	491.73M	398.20M	214.20M	140.83M	119.07M
United States Growth	23.49%	85.90%	52.10%	18.27%	16.39%
Total	491.73M	398.20M	214.20M	140.83M	119.07M
Total Growth	23.49%	85.90%	52.10%	18.27%	16.39%

Source: S&P Global Market Intelligence.